Dr. Alsuwaidan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
601 N 30th St
Omaha, NE 68131Phone+1 402-280-3436Fax+1 402-280-5247
Education & Training
Creighton University School of Medicine (Omaha)Residency, Pathology-Anatomic and Clinical, 2013 - 2017
King Faisal University College of MedicineClass of 2006
Certifications & Licensure
PA State Medical License 2016 - 2022
NE State Medical License 2016 - 2018- American Board of Pathology Pathology - Anatomic/Pathology - Clinical
- American Board of Pathology Pathology - Molecular Genetic
- American Board of Pathology Hematopathology
Publications & Presentations
PubMed
- 3 citationsA Combined Biomarker of Bright CD38 and MYC ≥55% Is Highly Predictive of Double-/Triple-Hit High-Grade B-Cell Lymphoma.Abdullah Alsuwaidan, Prasad Koduru, Franklin Fuda, Jesse Manuel Jaso, Mingyi Chen
American Journal of Clinical Pathology. 2022-09-02 - Molecular Association of Medulloblastoma and Sarcoidosis: Case Report and Review of the LiteratureTurki Elarjani, Malak Altewerki, Abdullah Alsuwaidan, Meshari Alhuthayl, Maher Hassounah
World Neurosurgery. 2021-01-01 - 24 citationsBright CD38 Expression by Flow Cytometric Analysis Is a Biomarker for Double/Triple Hit Lymphomas with a Moderate Sensitivity and High SpecificityAbdullah Alsuwaidan, Elaina Pirruccello, Jesse Jaso, Prasad Koduru, Rolando Garcia
Cytometry. Part B, Clinical Cytometry. 2019-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
